FDA Approves Lilly's Inluriyo-Verzenio Breast Cancer Combination The FDA approved Inluriyo with Verzenio for a biomarker-defined metastatic breast cancer population, citing...

https://www.narrowit.com/news/lilly-inluriyo-verzenio-fda-approval-2026-09-20
#EliLilly #Inluriyo #Verzenio #FDA

FDA Greenlights Inluriyo in Combination with Verzenio for Advanced Breast Cancer #United_States #Indianapolis #Breast_Cancer #Verzenio #Inluriyo